196 related articles for article (PubMed ID: 33761081)
1. Long-term follow-up results of fluorescence and blue dye guided sentinel lymph node biopsy in early breast cancer.
Wang C; Tong F; Cao Y; Liu P; Zhou B; Liu H; Cheng L; Liu M; Guo J; Xie F; Yang H; Wang S; Peng Y; Wang S
Breast Cancer Res Treat; 2021 Jul; 188(2):361-368. PubMed ID: 33761081
[TBL] [Abstract][Full Text] [Related]
2. Comparison of sentinel lymph node biopsy guided by indocyanine green, blue dye, and their combination in breast cancer patients: a prospective cohort study.
Guo J; Yang H; Wang S; Cao Y; Liu M; Xie F; Liu P; Zhou B; Tong F; Cheng L; Liu H; Wang S
World J Surg Oncol; 2017 Nov; 15(1):196. PubMed ID: 29096643
[TBL] [Abstract][Full Text] [Related]
3. Axillary lymph node recurrence after sentinel lymph node biopsy performed using a combination of indocyanine green fluorescence and the blue dye method in early breast cancer.
Inoue T; Nishi T; Nakano Y; Nishimae A; Sawai Y; Yamasaki M; Inaji H
Breast Cancer; 2016 Mar; 23(2):295-300. PubMed ID: 25348937
[TBL] [Abstract][Full Text] [Related]
4. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
Somashekhar SP; Kumar CR; Ashwin KR; Zaveri SS; Jampani A; Ramya Y; Parameswaran R; Rakshit S
Clin Breast Cancer; 2020 Oct; 20(5):e576-e583. PubMed ID: 32389561
[TBL] [Abstract][Full Text] [Related]
5. Indocyanine green combined with methylene blue versus methylene blue alone for sentinel lymph node biopsy in breast cancer: a retrospective study.
Yang QH; Zhang XJ
BMC Surg; 2023 May; 23(1):133. PubMed ID: 37198675
[TBL] [Abstract][Full Text] [Related]
6. Indocyanine Green and Methylene Blue Dye Guided Sentinel Lymph Node Biopsy in Early Breast Cancer: A Single-Center Retrospective Survival Study in 1574 Patients.
Yang R; Dong C; Jiang T; Zhang X; Zhang F; Fan Z
Clin Breast Cancer; 2023 Jun; 23(4):408-414. PubMed ID: 36907808
[TBL] [Abstract][Full Text] [Related]
7. Comparing single or dual tracing modality on sentinel lymph node biopsy from patients who plan to omitting axillary lymph node dissection referring to the criteria of Z0011 trial: a retrospective study.
Xu Y; Wu H; Zhang W; Shen Y; Jiang Y; Meng L
Updates Surg; 2022 Jun; 74(3):1073-1078. PubMed ID: 35389176
[TBL] [Abstract][Full Text] [Related]
8. Indocyanine Green Fluorescence Versus Blue Dye or Radioisotope Regarding Detection Rate of Sentinel Lymph Node Biopsy and Nodes Removed in Breast Cancer: A Systematic Review and Meta-Analysis.
Thongvitokomarn S; Polchai N
Asian Pac J Cancer Prev; 2020 May; 21(5):1187-1195. PubMed ID: 32458621
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the indocyanine green dye method versus the combined method of indigo carmine blue dye with indocyanine green fluorescence imaging for sentinel lymph node biopsy in breast conservative therapy for stage ≤IIA breast cancer.
Takemoto N; Koyanagi A; Yasuda M; Yamamoto H
BMC Womens Health; 2018 Sep; 18(1):151. PubMed ID: 30227837
[TBL] [Abstract][Full Text] [Related]
10. Indocyanine green detects sentinel lymph nodes in early breast cancer.
Liu J; Huang L; Wang N; Chen P
J Int Med Res; 2017 Apr; 45(2):514-524. PubMed ID: 28415938
[TBL] [Abstract][Full Text] [Related]
11. Short-term and long-term outcomes of indocyanine green for sentinel lymph node biopsy in early-stage breast cancer.
Hua B; Li Y; Yang X; Ren X; Lu X
World J Surg Oncol; 2022 Aug; 20(1):253. PubMed ID: 35941602
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer.
Agrawal SK; Hashlamoun I; Karki B; Sharma A; Arun I; Ahmed R
JCO Glob Oncol; 2020 Jul; 6():1225-1231. PubMed ID: 32749861
[TBL] [Abstract][Full Text] [Related]
13. Triple mapping for axillary staging after neoadjuvant therapy: Axillary reverse mapping with indocyanine green and dual agent sentinel lymph node biopsy.
Tasdoven I; Balbaloglu H; Erdemir RU; Bahadir B; Guldeniz Karadeniz C
Medicine (Baltimore); 2022 Dec; 101(52):e32545. PubMed ID: 36596061
[TBL] [Abstract][Full Text] [Related]
14. Preliminary study of contrast-enhanced ultrasound in combination with blue dye vs. indocyanine green fluorescence, in combination with blue dye for sentinel lymph node biopsy in breast cancer.
Zhou Y; Li Y; Mao F; Zhang J; Zhu Q; Shen S; Lin Y; Zhang X; Liu H; Xiao M; Jiang Y; Sun Q
BMC Cancer; 2019 Oct; 19(1):939. PubMed ID: 31604469
[TBL] [Abstract][Full Text] [Related]
15. Indocyanine green fluorescence method for sentinel lymph node biopsy in breast cancer.
Lin J; Lin LS; Chen DR; Lin KJ; Wang YF; Chang YJ
Asian J Surg; 2020 Dec; 43(12):1149-1153. PubMed ID: 32143963
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the benefit of using blue dye in addition to indocyanine green fluorescence for sentinel lymph node biopsy in patients with breast cancer.
Guo W; Zhang L; Ji J; Gao W; Liu J; Tong M
World J Surg Oncol; 2014 Sep; 12():290. PubMed ID: 25239029
[TBL] [Abstract][Full Text] [Related]
17. Clinical utility of the additional use of blue dye for indocyanine green for sentinel node biopsy in breast cancer.
Ji Y; Luo N; Jiang Y; Li Q; Wei W; Yang H; Liu J
J Surg Res; 2017 Jul; 215():88-92. PubMed ID: 28688667
[TBL] [Abstract][Full Text] [Related]
18. Utilization of Indocyanine Green to Aid in Identifying Sentinel Lymph Nodes in Merkel Cell Cancer.
Knackstedt RW; Knackstedt T; Gastman B
J Surg Res; 2018 Dec; 232():365-368. PubMed ID: 30463742
[TBL] [Abstract][Full Text] [Related]
19. Clinical study of combined application of indocyanine green and methylene blue for sentinel lymph node biopsy in breast cancer.
Zhang C; Li Y; Wang X; Zhang M; Jiang W; Ou J
Medicine (Baltimore); 2021 Apr; 100(15):e25365. PubMed ID: 33847634
[TBL] [Abstract][Full Text] [Related]
20. Comparison between the indocyanine green fluorescence and blue dye methods for sentinel lymph node biopsy using novel fluorescence image-guided resection equipment in different types of hospitals.
He K; Chi C; Kou D; Huang W; Wu J; Wang Y; He L; Ye J; Mao Y; Zhang GJ; Wang J; Tian J
Transl Res; 2016 Dec; 178():74-80. PubMed ID: 27497181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
